FIELD: medicine.
SUBSTANCE: invention refers to a new compound of formula or to its pharmaceutically acceptable salt. What is prepared and described is the new compound applicable as a modulator of ATP-binding cartridge (ABC) transporter or their fragments including a cystic fibrosis transmembrane regulator (CFTR).
EFFECT: higher efficacy.
1 cl, 422 ex, 7 tbl
Title | Year | Author | Number |
---|---|---|---|
HETEROCYCLIC MODULATORS OF TRANSPORTERS OF AN ATP-BINDING CASSETTE | 2016 |
|
RU2765714C2 |
HETEROCYCLIC MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS | 2012 |
|
RU2608610C2 |
MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS | 2008 |
|
RU2512682C2 |
MODULATORS OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE | 2007 |
|
RU2459821C2 |
MODULATORS OF ATP-BINDING CARTRIDGE TRANSPORTERS | 2012 |
|
RU2640420C2 |
METHODS AND INTERMEDIATE COMPOUNDS | 2010 |
|
RU2531588C2 |
PPAR-SUPPORTING COMPOUNDS FOR TREATING METABOLIC DISEASES | 2014 |
|
RU2687490C2 |
PPAR-SUPPORTING THIAZOLIDINEDIONES AND THEIR COMBINATIONS FOR TREATMENT OF NEURODEGENERATIVE DISEASES | 2010 |
|
RU2570424C2 |
THIAZOLIDINEDIONE SALTS WITH REDUCED AFFINITY TO PPAR FOR TREATMENT OF METABOLIC DISORDERS | 2010 |
|
RU2564661C2 |
METHODS AND INTERMEDIATE PRODUCTS | 2006 |
|
RU2446171C2 |
Authors
Dates
2012-10-10—Published
2006-11-08—Filed